SC 13G
ALIGOS THERAPEUTICS, INC.
- Company
- Aligos Therapeutics, Inc.
- Filed
- November 12, 2024
- Accession Number
- 0000902664-24-006398
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →